Greenwich LifesciencesGLSI
13F holders, Q2 2024 (June 30)34holders +3
12new positions
10sold out
1famous investor
$17.26avg. 13F price*
At the end of Q2 2024, 34 institutions reported holding Greenwich Lifesciences Inc. (GLSI) in their 13F filings, up 3 from Q1 2024. 12 opened new positions and 10 sold out. The largest holders were BlackRock Inc. ($5.3M), Vanguard Group Inc. ($4.6M) and Geode Capital Management, LLC ($2.2M). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Greenwich Lifesciences Inc.
- CUSIP
- 396879108
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 12 | $2.5M |
| Exits | 10 | $3.9M |
All 13F filers, Q1 2024 → Q2 2024: 578,807 shares bought and 205,933 shares sold, net +372,874 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 34 holders
| BlackRock Inc. | 0.00% | Add +447.1% | 308,909 | $5.3M |
| Vanguard Group Inc. | 0.00% | Add +20.2% | 268,168 | $4.6M |
| Geode Capital Management, LLC | 0.00% | Add +119.2% | 127,689 | $2.2M |
| Credit Agricole S A | 0.01% | New | 87,000 | $1.5M |
| State Street Corp. | 0.00% | Add +426.1% | 68,403 | $1.2M |
| Renaissance Technologies | 0.00% | Reduce -1.6% | 36,900 | $637K |
| Northern Trust Corp. | 0.00% | Add +14.6% | 24,320 | $420K |
| Charles Schwab Investment Management Inc. | 0.00% | New | 18,454 | $319K |
| Man Group plc | 0.00% | Add +46.5% | 16,650 | $287K |
| Bank of New York Mellon Corp | 0.00% | New | 15,295 | $264K |
| Morgan Stanley | 0.00% | Add +13.2% | 7,053 | $122K |
| Rhumbline Advisers | 0.00% | New | 6,799 | $117K |
| Bank of America Corp. | 0.00% | Add +12.3% | 6,328 | $109K |
| New York State Common Retirement Fund | 0.00% | New | 6,000 | $104K |
| STRS Ohio | 0.00% | New | 4,800 | $83K |
| Corebridge Financial, Inc. | 0.00% | — | 3,212 | $55K |
| JPMorgan Chase & Co. | 0.00% | Reduce -55.1% | 2,548 | $44K |
| Barclays PLC | 0.00% | New | 2,022 | $35K |
| Wells Fargo & Company | 0.00% | Add +4561.0% | 1,911 | $33K |
| NFSG Corp | 0.01% | Add +26.7% | 1,900 | $33K |
| UBS Group AG | 0.00% | Add +349.5% | 1,807 | $31K |
| Citigroup Inc. | 0.00% | Reduce -84.3% | 1,299 | $22K |
| Legal & General Group Plc | 0.00% | New | 662 | $11K |
| Ameritas Investment Partners, Inc. | 0.00% | New | 585 | $10K |
| Royal Bank of Canada | 0.00% | Add +3907.1% | 561 | $10K |
| Founders Capital Management | 0.01% | No change | 500 | $9K |
| California State Teachers Retirement System | 0.00% | New | 433 | $7K |
| Amalgamated Bank | 0.00% | New | 207 | $4K |
| Washington Trust Advisors, Inc. | 0.00% | No change | 200 | $3K |
| FMR LLC | 0.00% | No change | 90 | $2K |
| Geneos Wealth Management Inc. | 0.00% | No change | 88 | $2K |
| Northwestern Mutual Wealth Management Co. | 0.00% | New | 60 | $1K |
| North Star Investment Management Corp. | 0.00% | No change | 51 | $880 |
| Capital Advisors, Ltd. LLC | 0.00% | Reduce -33.3% | 2 | $0 |
"% of holder's portfolio" is GLSI's weight in each manager's 13F, not the share of Greenwich Lifesciences Inc. the manager owns.